BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31810583)

  • 1. [Off-label use of vincristine for intralesional treatment of isolated papules in Kaposi's sarcoma: Dermatologic experience with 10 patients].
    Peduto T; Fabbrocini G; Delfino M; Nappa P; Guarino M; Cillo F
    Ann Dermatol Venereol; 2020 Feb; 147(2):140-143. PubMed ID: 31810583
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.
    Brambilla L; Bellinvia M; Tourlaki A; Scoppio B; Gaiani F; Boneschi V
    Br J Dermatol; 2010 Apr; 162(4):854-9. PubMed ID: 19995366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal: Disseminated Kaposi's sarcoma.
    Le Mouel JP; Chatelain D; Hautefeuille V
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1309. PubMed ID: 29607543
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine.
    Nazzaro G; Genovese G; Tourlaki A; Passoni E; Berti E; Brambilla L
    Skin Res Technol; 2019 Mar; 25(2):200-203. PubMed ID: 30311687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
    Flaitz CM; Nichols CM; Hicks MJ
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A juvenile case of classic Kaposi's sarcoma.
    Erdem T; Atasoy M; Akdeniz N; Parlak M; Ozdemir S
    Acta Derm Venereol; 1999 Nov; 79(6):492-3. PubMed ID: 10598779
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistently recurring Mediterranean Kaposi's sarcoma on skin grafts.
    Brambilla L; Boneschi V; Zampieri M; Bruognolo L; Fossati S
    Int J Dermatol; 1996 May; 35(5):362-4. PubMed ID: 8734662
    [No Abstract]   [Full Text] [Related]  

  • 9. Intralesional chemotherapy for Kaposi's sarcoma.
    Brambilla L; Boneschi V; Beretta G; Finzi AF
    Dermatologica; 1984; 169(3):150-5. PubMed ID: 6207059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cutaneous Kaposi's sarcoma with intralesional vincristine.
    Odom RB; Goette DK
    Arch Dermatol; 1978 Nov; 114(11):1693-4. PubMed ID: 718222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
    Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
    Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
    McCormick SU
    J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Turiansky G; Wagner KF
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients.
    Vassallo C; Carugno A; Derlino F; Ciocca O; Brazzelli V; Borroni G
    Cutis; 2015 May; 95(5):E28-34. PubMed ID: 26057517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapy.
    Burdick AE; Carmichael C; Rady PL; Tyring SK; Badiavas E
    J Am Acad Dermatol; 1997 Oct; 37(4):648-9. PubMed ID: 9344209
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of classical type Kaposi's sarcoma with paclitaxel.
    Chao SC; Lee JY; Tsao CJ
    Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
    Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-TerĂ¡n G
    Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: report of a case.
    Simonart T; Noel JC; De Dobbeleer G; Parent D; Van Vooren JP; De Clercq E; Snoeck R
    J Med Virol; 1998 Jul; 55(3):215-8. PubMed ID: 9624609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
    Baskan EB; Tunali S; Adim SB; Kiyici M; Ali R
    Int J Dermatol; 2006 Dec; 45(12):1441-3. PubMed ID: 17184252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.